AI may make clinical supply forecasting faster, but cheaper tokens can drive higher costs. See how to measure AI at scale before a pilot becomes an expensive surprise.
- Clinical Trial Supply Chains Are Entering The Era Of Predictive Risk Management
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- CSM Feasibility Begins With Research Strategy And Study Design
- Clinical Supply Systems Need IT General Controls
- AI-Generated Data, Patent Protection, And The Implications For Clinical Supply
- The End Of Just-In-Time? Why Clinical Trial Supply Chains Are Rethinking Inventory Strategy
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
- Last-Mile Lessons For Depot-To-Site Delivery
ON-DEMAND WEBINARS
Gain insights into managing global trial complexity, balancing accelerated timelines with compliance, using advanced technologies to improve efficiency, and leveraging partnerships to support seamless clinical operations.
Join patient-centric supply chain expert Marco Hogenboom for a discussion on how to accelerate the delivery of advanced therapies in an unpredictable environment through supply chain customization from clinical to commercialization.
The complexities of sample collection and logistics in advanced therapy studies naturally brings chain of custody challenges in protecting the integrity of a trials’ high value samples. Learn about end to end sample management strategies, logistical integration planning, real-time tracking and LIVE monitoring technologies.
CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![clinical-trial-supply-challenges-GettyImages-2161372208]( "Managing Clinical Trial Supply Challenges In Complex Studies")
Managing Clinical Trial Supply Challenges In Complex StudiesComplex studies require flexible supply strategies that can adjust to shifting timelines, varied modalities, and global site needs. Adaptive, scalable planning helps lower risk.
-
![Doctor Patient Engagement]( "Distributing Clinical Supply In The EU For Compassionate Use Programs")
Distributing Clinical Supply In The EU For Compassionate Use ProgramsExplore the logistical and distribution risk management factors that need to be considered when planning an EU Compassionate Use Program, especially when faced with COVID-19 closures and challenges.
-
![GettyImages-820427458 clinical trials]( "Ensure Seamless, Efficient Delivery Of Clinical Trial Materials Worldwide")
Ensure Seamless, Efficient Delivery Of Clinical Trial Materials WorldwideDrug discovery companies, CROs, and CDMOs are under pressure to find supply management solutions that ensure delivery of clinical trial materials while navigating complex study designs and the regulatory landscape.
-
![pharma-success-GettyImages-2217587867]( "Why Advanced cGMP Manufacturing Is Key to Pharma Success")
Why Advanced cGMP Manufacturing Is Key to Pharma SuccessAdvanced cGMP facilities deliver control, expertise, and reliable processes that protect quality and support smooth progress to market. Strong partnerships help reduce risk in complex programs.
-
![Ampoule Aseptic Filling GettyImages-1490244818]( "Advantages Of Robotic Aseptic Processing")
Advantages Of Robotic Aseptic ProcessingExamine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
![Europe Globe Map Data GettyImages REV-1319209608]( "How Regional Logistics Strategy Supports Clinical Success In Europe")
How Regional Logistics Strategy Supports Clinical Success In EuropeIn an era where trial delays, customs bottlenecks, and fragmented regulations can derail even the most promising program, logistics has become a strategic asset.
-
![China Globe World]( "Optimizing Clinical Trials In China With Strategic Solutions For Supply Chain")
Optimizing Clinical Trials In China With Strategic Solutions For Supply ChainPlan proactively for clinical trials in China by aligning with National Medical Products Administration requirements and leveraging Free Trade Zones to streamline regulatory approvals and clinical supply importation.
-
![GettyImages-1296498102 lab technician]( "Clinical Supply Optimization: Process Improvement Accelerates Trials")
Clinical Supply Optimization: Process Improvement Accelerates TrialsA biopharmaceutical sponsor required the study start-up phase to be reduced to 91 days, involving comparator sourcing and blinding, kitting, packaging, labeling, and distribution to the sites.
-
![GettyImages-2169608710-blister-packaging-pill-nutraceutical]( "Rare Diseases And The Integrated CDMO Support System")
Rare Diseases And The Integrated CDMO Support SystemChampion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
![West_GCApp_MG (person picking up container)]( "Understanding Injectable Drug Container Closure Systems")
Understanding Injectable Drug Container Closure SystemsChoosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
- Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
- Could Smarter Use of Clinical Supply Data Help Avoid Certain Protocol Amendments?
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
